The global upper airway stimulation (UAS) market, currently valued at US$ 572.4 million in 2023, is poised for substantial growth in the coming decade. With the increasing incidence of obstructive sleep apnea (OSA) and growing awareness about innovative treatment methods, the market is projected to expand at a compound annual growth rate (CAGR) of 12.3%, reaching a market size of US$ 2,050.6 million by 2034. Request a Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10413